
Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company's IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company's anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.
我們正在追蹤 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的市場擴張
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的國際擴張與競爭對手的比較
長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.你 | 0 | 0 | — | 0 | 0 |
目前並無招聘
註冊以追蹤此公司,並在發生變化時第一時間獲得提醒。
無進行中的廣告活動
註冊以追蹤此公司,並在發生變化時第一時間獲得提醒。
全球水光針市場預計2032年達238億元,年複合增長率為10.6%。市場增長由非手術美容治療和皮膚保濕需求增加推動。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 業務、市場及增長訊號的快速解答。
